Walleye Capital’s AtriCure ATRC Stock Holding History

Walleye Capital’s Portfolio ATRC Stock Details ATRC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-9,800	Closed	-$292K	–	1894
2019 Q2	$292K	Buy	+9,800	New	+$286K	0.03%	746

Other funds holding ATRC

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

FLAM

First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return

HRCM

Hood River Capital Management Palm Beach Gardens, Florida $9.98B AUM 145.42% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Walleye Capital's ATRC Position: Q2 2024 in Review

Walleye Capital sold out of AtriCure (ATRC) in Q2 2024, closing a stake of 10,588 shares — an estimated $322K sold.

Walleye Capital first reported a position in ATRC in Q3 2020 and held it in 7 quarters. The position peaked at $4.04M in Q4 2023. 197 funds tracked by Wall St. Rank hold ATRC as of Q2 2024.

Walleye Capital reported no remaining AtriCure position as of Q2 2024 after selling out during the quarter.
Walleye Capital sold 10,588 AtriCure shares in Q2 2024, an estimated $322K.
Walleye Capital first reported a position in AtriCure in Q3 2020 and held it in 7 quarters.
Walleye Capital's AtriCure position peaked at $4.04M in Q4 2023.
197 funds tracked by Wall St. Rank held AtriCure as of Q2 2024.

Based on Walleye Capital's 13F filing for Q2 2024, filed 14 Aug 2024.